Autopsy report · NCT01228266

Mesenchymal Stem Cell Transplantation in MS

“Ended the recruitment in June 2012 for low enrollement accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 3 years before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Albert Saiz

Sponsor type

University, hospital or other

Conditions

Multiple Sclerosis

Interventions

autologous mesenchymal stem cells

Participants

9

Sites

1

Countries

Spain

Trials that died the same way

• A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment
  “No funding stopped recruitment march 2014 with only 14 enrolled” (70% match in meaning)
• Olaparib for PAH: a Multicenter Clinical Trial
  “The recruitment was stopped on October 31st 2024 due to limited recruitment within the last year, as well as the end of funding (Spring 2025).” (69% match in meaning)
• Comparison of DSCT With IB-IVUS and Angiography in the Assessment of Coronary Artery Disease
  “Subject recruitment was slow, so enrollment has been closed.” (69% match in meaning)
• Comparison of the Performance of ICM and CIED in Detecting AF
  “Recruitment to study was insufficient. This was despite extending the recruitment period. Decision taken to terminate study due to lack of recruitment.” (68% match in meaning)
• Knee Nerve Cryoneurolysis and Impact on Pain After Prosthetic Surgery
  “the recruitment rate is far too low despite an 18-month extension of the inclusion period” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.